USA: A new study published in the Journal of Diabetes and Its Complications suggests that tirzepatide, a novel dual ...

Data from a limited number of trials hint that GLP-1 use might improve erectile dysfunction and testosterone levels for men, but more research is needed to provide a clearer picture, researchers ...

In a study in the Journal of Clinical Medicine, a certain group of men actually improved their erectile function and sperm count over four months—but the men were specifically those with obesity ...

A new study conducted on medical students found that those who suffer from Irritable Bowel Syndrome are 108 percent more likely to develop erectile dysfunction.

The authors note that other classes of drugs have been found to cause NAION, including erectile dysfunction and anti-arrhythmia drugs. In some cases, research has led to changes in labeling.

Urologists are setting up a study that explores the use of low-intensity shockwave therapy as a way to treat erectile dysfunction and possibly repair the thwarted blood flow that causes it.

A study found a 108 percent higher prevalence of erectile dysfunction in those with irritable bowel syndrome than those without.

The health study found medications commonly prescribed for erectile dysfunction are associated with significant reductions in deaths, cardiovascular disease, and dementia ...

Semaglutide and other new drugs are the real deal in obesity treatment, but there are many lingering questions about their future.

For the first time, researchers have shown that erectile dysfunction is a strong predictor of the likelihood that men will die of heart disease.

The authors note that other classes of drugs have been found to cause NAION, including erectile dysfunction and anti-arrhythmia drugs. In some cases, research has led to changes in labeling.